市場調査レポート

商品コード

欧州の感染症用分子診断：2030年市場予測- 地域別分析- タイプ別、エンドユーザー別、用途別、疾患タイプ別、感染タイプ別

Europe Molecular Diagnostics for Infectious Disease Market Forecast to 2030 - Regional Analysis - by Type (Point-of-Care Testing and Laboratory Testing), End User, Application, Disease Type, Infection Type

出版日: 2024年03月14日
発行: The Insight Partners
ページ情報: 英文 162 Pages
納期: 即納可能

価格

PDF (Single User License)

USD 3,450 506,529円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 4,450 653,349円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 5,450 800,169円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

欧州の感染症用分子診断市場は、2022年に23億4,642万米ドルと評価され、2030年には59億4,840万米ドルに達すると予測され、2022年から2030年までのCAGRは12.3%で成長すると予測されています。

獣医感染症における分子診断の用途拡大が欧州感染症用分子診断市場を後押し

新興の伝染性動物疾病を早期に発見できる診断技術は、そのような疾病の発生に伴う経済的損失を削減するために不可欠です。ポリメラーゼ連鎖反応（PCR）は、動物病原体の検出に世界的に最も広く使用されている分子アッセイです。この種の診断法は使いやすく、費用対効果に優れ、高感度で特異的であり、大量検出が可能です。

ポイント・オブ・ケア診断法（POCDs）は、現場レベルで病気の状態を検出できる、簡便、迅速、携帯可能な診断機器です。近年、リアルタイムPCR（qPCR）がPOCDプラットフォームに移行しています。これらの完全に自動化されたプラットフォームは、核酸抽出、サーマルサイクリング、現場での結果報告を兼ね備えています。例えば、エニグマ・ダイアグノスティックス社のMiniLabは10-35kgの分子診断プラットフォームであり、現場レベルで携帯され、豚熱ウイルス、鳥インフルエンザウイルス、古典的豚熱ウイルス、口蹄疫ウイルスを研究目的で検証するために使用されます。英国Primerdesign社のgenesig検出キットは、研究目的でウシ62種、ウマ42種、ブタ47種、鳥60種、イヌ40種、ネコ26種の病原体を診断するための凍結乾燥qPCRアッセイキットを供給しています。同様に、ボスター社は最大48検体までの個別またはプール検体を検出するBosterbio qPCRキットを提供しています。これは、遺伝子発現プロファイリング、標的DNA定量、微生物検出、ウイルスまたは細菌病原体負荷量測定、プローブベースのqPCR用プライマーペアの性能評価に使用されます。

このように、動物の細菌、ウイルス、真菌、寄生虫感染を診断するためのPCRやqPCRのような分子診断法は、血清学的、顕微鏡的、培養ベースの技術のような従来の方法に取って代わることができます。

欧州の感染症用分子診断市場概要

欧州の感染症用分子診断市場は、ドイツ、英国、フランス、イタリア、スペイン、オーストリア、ベルギー、オランダ、ルクセンブルグ、その他欧州に区分されます。同地域は世界の感染症用分子診断市場で大きなシェアを占めており、2022～2030年に顕著なCAGRを記録すると予測されています。欧州の市場成長の背景には、ライフサイエンス研究の活発化と感染症検査への政府投資の増加があります。ロバート・コッホ研究所の論文に掲載されたデータによると、ドイツでは2021年に3,900件の結核患者が登録されました。この調査によると、ドイツの検査場訪問者の～5％が性病に罹患していました。さらに、クラミジアと淋病検査のための年間訪問者数は17％（2017年）から42％（2020年）に増加しています。INSTITUT PASTEURによると、フランスでは毎年200万～800万人がインフルエンザに罹患し、1万～1万5千人の患者がインフルエンザが原因で死亡しています。毎年季節的に流行するため、公衆衛生上の問題となっています。他のウイルス感染症も増加傾向にあります。INSTITUT PASTEURによると、13万4,000人がC型慢性肝炎ウイルス（HCV）感染症に罹患しており、毎年4,000人が新たに感染しています。WHOによると、2020年、イタリアでは感染症および寄生虫症が原因で13,786人が死亡したと報告されています。同様に、1,303人のHIV感染者が診断され、人口10万人当たりの発症率は2.2でした。人口問題研究所によると、イタリアの高齢化率は2022年には24％で、2040年には30％に達すると予想されています。分子診断用途で使用される技術は、PCR増幅、シークエンシング、核酸単離と定量化、STR分析などの中核的な分子生物学的手法です。

欧州の感染症用分子診断市場の収益と2030年までの予測（百万米国ドル）

欧州の感染症用分子診断市場セグメンテーション

欧州の感染症用分子診断市場は、タイプ、エンドユーザー、用途、疾患タイプ、感染タイプ、国によって区分されます。

タイプ別では、欧州感染症用分子診断市場はポイントオブケア検査とラボ検査に二分されます。2022年の欧州感染症用分子診断市場は、ラボラトリー検査分野が大きなシェアを占めています。

欧州感染症用分子診断市場は、エンドユーザー別にポイントオブケア検査とラボ検査に二分されます。ポイントオブケア検査はさらにヒト検査と獣医検査に二分されます。同様に、ラボ検査はヒト検査と獣医検査にさらに二分されます。2022年の欧州感染症用分子診断市場シェアは、ポイントオブケア検査によるヒト用検査分野が大きいです。さらに、ラボ検査によるヒト検査セグメントは、2022年の欧州感染症用分子診断市場においてより大きなシェアを占めました。

用途別に見ると、欧州感染症用分子診断市場はポイントオブケア検査とラボ検査に二分されます。ポイントオブケア検査はさらに、単一病原体の検出、2種類以上の病原体の検出、新興の新規感染症の評価、生物脅威因子や疾患関連バイオマーカーのサーベイランスと早期検出、抗菌薬耐性プロファイリングに区分されます。同様に、臨床検査はさらに、患者層別化、薬剤レジメン選択、毒性回避、治療モニタリング、疾患素因の検出に分類されます。2022年の欧州感染症用分子診断市場シェアは、ポイントオブケア検査による単一病原体の検出分野が最大でした。また、検査室検査による薬剤レジメン選択分野は、2022年に欧州感染症用分子診断市場で最大のシェアを占めました。

疾患タイプに基づき、欧州感染症用分子診断市場はポイントオブケア検査とラボ検査に二分されます。ポイントオブケア検査はさらに、敗血症（泌尿生殖器／肺／創傷など）、人工関節感染、心内膜炎、性病、単核球症、A群連鎖球菌、その他に区分されます。同様に、ラボ検査はさらに敗血症、人工関節感染症、心内膜炎、STDs、クラミジア、胃腸感染症、結核、H1N1ウイルス、その他に分類されます。2022年の欧州感染症用分子診断市場シェアは、ポイントオブケア検査によるSTDs分野が最大でした。また、ラボ検査によるSTDs分野は、2022年に欧州感染症用分子診断市場で最大のシェアを占めました。

感染症タイプに基づき、欧州感染症用分子診断市場はポイントオブケア検査とラボ検査に二分されます。ポイントオブケア検査はさらに細菌、ウイルス、真菌、その他に区分されます。同様に、ラボ検査はさらに細菌、ウイルス、真菌、その他に分類されます。2022年の欧州感染症用分子診断市場シェアは、ポイントオブケア検査による細菌セグメントが最大でした。また、ラボ検査による細菌セグメントは、2022年に欧州感染症用分子診断市場で最大のシェアを占めました。

国別では、欧州感染症用分子診断市場はドイツ、英国、フランス、イタリア、スペイン、オーストリア、ベルギー、オランダ、ルクセンブルグ、その他欧州に分類されます。2022年の欧州感染症用分子診断市場はドイツが支配的でした。

Abbott Laboratories、bioMerieux SA、Bruker Corp、Danaher Corp、DiaSorin SpA、F. Hoffmann-La Roche Ltd、Hologic Inc、Molzym GmbH &Co KG、Siemens Healthineers AG、Thermo Fisher Scientific Incは、欧州感染症用分子診断市場に参入している主要企業です。

List Of Tables

Table 1. Europe Molecular Diagnostic for Infectious Diseases Market Segmentation
Table 2. Europe Molecular Diagnostic for Infectious Diseases Market, for Point of Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 4. Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 6. Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 7. Europe Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)
Table 8. Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 9. Europe Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)
Table 10. Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 11. Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 12. UK Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. UK Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. UK Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 15. UK Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 16. UK Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 17. UK Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 18. UK Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)
Table 19. UK Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 20. UK Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)
Table 21. UK Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 22. UK Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 23. Germany Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 24. Germany Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 25. Germany Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 26. Germany Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 27. Germany Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 28. Germany Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 29. Germany Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)
Table 30. Germany Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 31. Germany Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)
Table 32. Germany Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 33. Germany Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 34. France Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 35. France Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 36. France Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 37. France Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 38. France Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 39. France Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 40. France Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)
Table 41. France Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 42. France Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)
Table 43. France Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 44. France Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 45. Italy Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 46. Italy Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 47. Italy Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 48. Italy Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 49. Italy Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 50. Italy Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 51. Italy Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)
Table 52. Italy Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 53. Italy Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)
Table 54. Italy Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 55. Italy Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 56. Spain Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 57. Spain Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 58. Spain Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 59. Spain Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 60. Spain Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 61. Spain Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 62. Spain Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)
Table 63. Spain Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 64. Spain Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)
Table 65. Spain Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 66. Spain Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 67. Austria Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 68. Austria Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 69. Austria Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 70. Austria Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 71. Austria Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 72. Austria Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 73. Austria Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)
Table 74. Austria Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 75. Austria Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)
Table 76. Austria Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 77. Austria Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 78. Belgium Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 79. Belgium Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 80. Belgium Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 81. Belgium Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 82. Belgium Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 83. Belgium Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 84. Belgium Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)
Table 85. Belgium Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 86. Belgium Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)
Table 87. Belgium Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 88. Belgium Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 89. Luxembourg Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 90. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 91. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 92. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 93. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 94. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 95. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)
Table 96. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 97. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)
Table 98. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 99. Luxembourg Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 100. The Netherlands Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 101. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 102. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 103. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 104. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 105. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 106. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)
Table 107. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 108. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)
Table 109. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 110. The Netherlands Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 111. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 112. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 113. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User - Revenue and Forecast to 2030 (US$ Million)
Table 114. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 115. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application - Revenue and Forecast to 2030 (US$ Million)
Table 116. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 117. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing - Revenue and Forecast to 2030 (US$ Million)
Table 118. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type - Revenue and Forecast to 2030 (US$ Million)
Table 119. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing - Revenue and Forecast to 2030 (US$ Million)
Table 120. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 121. Rest of Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type - Revenue and Forecast to 2030 (US$ Million)
Table 122. Organic Developments Done By Companies
Table 123. Inorganic Developments Done By Companies
Table 124. Glossary of Terms, Molecular Diagnostic for Infectious Diseases Market

List Of Figures

Figure 1. Europe Molecular Diagnostic for Infectious Diseases Market Segmentation, By Country
Figure 2. Europe Molecular Diagnostic for Infectious Diseases Market, by Country, Market attractiveness
Figure 3. Europe Molecular Diagnostic for Infectious Diseases Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Molecular Diagnostic for Infectious Diseases Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Europe Molecular Diagnostic for Infectious Diseases Market Revenue Share, by Type, 2022 & 2030 (%)
Figure 7. Point-of-Testing: Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Laboratory Testing: Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing and Laboratory Testing by End User, 2022 & 2030 (%)
Figure 10. Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Application, 2022 & 2030 (%)
Figure 11. Europe Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Disease Type, 2022 & 2030 (%)
Figure 12. Europe Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Infection Type, 2022 & 2030 (%)
Figure 13. Europe Molecular Diagnostic for Infectious Diseases Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 14. Europe Molecular Diagnostic for Infectious Diseases Market, By Key Countries, 2022 and 2030 (%)
Figure 15. UK Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 16. Germany Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 17. France Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 18. Italy Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 19. Spain Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 20. Austria Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 21. Belgium Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 22. Luxembourg Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. The Netherlands Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Rest of Europe Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Growth Strategies Done by the Companies in the Market, (%)

Product Code: BMIRE00029840

The Europe molecular diagnostics for infectious disease market was valued at US$ 2,346.42 million in 2022 and is expected to reach US$ 5,948.40 million by 2030; it is estimated to grow at a CAGR of 12.3% from 2022 to 2030.

Rising Application of Molecular Diagnostics in Veterinary Infectious Diseases Fuels the Europe Molecular Diagnostics for Infectious Disease Market

Diagnostic technologies that can detect emerging infectious animal diseases at an early stage are essential for reducing economic losses associated with outbreaks of such diseases. Polymerase chain reaction (PCR) remains the most widely used molecular assay globally for detecting animal pathogens. Diagnostic methods of this type are easy to use, cost-effective, highly sensitive, and specific, with the ability to detect at a high volume.

Point-of-care diagnostics (POCDs) are simple, rapid, and portable diagnostic devices that can detect the disease status at the field level. In recent years, real-time PCR (qPCR) has been transitioned into a POCD platform. These fully automated platforms combine nucleic acid extraction, thermal cycling, and on-site reporting results. For instance, MiniLab from Enigma Diagnostics is a molecular diagnostic platform of 10-35 kg that is carried at the field level and used for validating swine fever virus, avian influenza virus, classical swine fever virus, and foot-and-mouth disease virus for research purposes. The genesig detection kits of Primerdesign Ltd, UK, supplies lyophilized qPCR assay kits for the diagnosis of 62 bovine, 42 equine, 47 porcine, 60 avian, 40 canine, and 26 feline pathogens for research purposes. Similarly, Boster offers Bosterbio qPCR kits to detect up to 48 individual or pooled samples. It is used for gene expression profiling, target DNA quantification, microbial detection, viral or bacterial pathogen load determination, and evaluation of primer pair performance for probe-based qPCR.

Thus, molecular diagnostics methods such as PCR and qPCR to diagnose bacterial, viral, fungal, and parasitic infections in animals can replace the conventional methods such as serological, microscopic, and culture-based techniques.

Europe Molecular Diagnostics for Infectious Disease Market Overview

The European molecular diagnostics for infectious disease market is segmented into Germany, the UK, France, Italy, Spain, Austria, Belgium, the Netherlands, Luxembourg, and the Rest of Europe. The region holds a significant share of the global molecular diagnostics for infectious disease market and is expected to register a notable CAGR during 2022-2030. The market growth in Europe is attributed to an upsurge in life science research and an increase in government investments in testing infectious diseases. According to the data published in an article by the Robert Koch Institute, ~3,900 tuberculosis cases were registered in Germany in 2021. According to this study, ~5% of the test-site visitors in Germany had STD. Moreover, the number of annual visitors for chlamydia and gonorrhea tests had increased from 17% (2017) to 42% (2020). As per the INSTITUT PASTEUR, in France, influenza affects 2-8 million people each year; 10,000-15,000 patients succumb to death due to influenza. It has become a public health issue due to its seasonal outbreaks every year. Other viral infections are also on the rise in the country. As per INSTITUT PASTEUR, 134,000 people are living with chronic hepatitis C virus (HCV) infection, with the addition of ~4,000 new cases annually. According to the WHO, in 2020, ~13,786 deaths were reported due to infectious and parasitic diseases in Italy. Similarly, ~1,303 HIV cases were diagnosed with an incidence of 2.2 per 100,000 residents. As per the Population Reference Bureau, the aging population in Italy was 24% in 2022, which is expected to reach 30% by 2040. Techniques that are used in molecular diagnostic applications are core molecular biology methods such as PCR amplification, sequencing, nucleic acid isolation and quantification, and STR analysis.

Europe Molecular Diagnostics for Infectious Disease Market Revenue and Forecast to 2030 (US$ Million)

Europe Molecular Diagnostics for Infectious Disease Market Segmentation

The Europe molecular diagnostics for infectious disease market is segmented based on type, end user, application, disease type, infection type, and country.

Based on type, the Europe molecular diagnostics for infectious disease market is bifurcated into point-of-care testing and laboratory testing. The laboratory testing segment held a larger Europe molecular diagnostics market for infectious disease market share in 2022.

The Europe molecular diagnostics for infectious disease market, by end user, is bifurcated into point-of-care testing and laboratory testing. Point-of-care testing is further bifurcated into human testing and vet testing. Similarly, laboratory testing is further bifurcated into human testing and vet testing. The human testing segment, by point-of-care testing, held a larger Europe molecular diagnostics market for infectious disease market share in 2022. Additionally, the human testing segment, by laboratory testing, held a larger Europe molecular diagnostics market for infectious disease market share in 2022.

Based on application, the Europe molecular diagnostics for infectious disease market is bifurcated into point-of-care testing and laboratory testing. Point-of-care testing is further segmented into detection of single pathogen, detection of two or more pathogens, evaluation of emerging novel infections, surveillance and early detection of biothreat agents and diseases-related biomarker, and antimicrobial resistance profiling. Similarly, laboratory testing is further categorized into patient stratification, drug regimen selection, toxicity avoidance, therapeutic monitoring, and detection of predisposition to disease. The detection of a single pathogen segment, by point-of-care testing, held the largest Europe molecular diagnostics for infectious disease market share in 2022. Additionally, the drug regimen selection segment, by laboratory testing, held the largest Europe molecular diagnostics for infectious disease market share in 2022.

Based on disease type, the Europe molecular diagnostics for infectious disease market is bifurcated into point-of-care testing and laboratory testing. Point-of-care testing is further segmented into sepsis (e.g. urogenital/lung/wound), prosthetic joint infection, endocarditis, STDs, mononucleosis, group A streptococcus, and others. Similarly, laboratory testing is further categorized into sepsis, prosthetic joint infection, endocarditis, STDs, chlamydia, gastrointestinal infection, tuberculosis, H1N1 virus, and others. The STDs segment, by point-of-care testing, held the largest Europe molecular diagnostics for infectious disease market share in 2022. Additionally, the STDs segment, by laboratory testing, held the largest Europe molecular diagnostics for infectious disease market share in 2022.

Based on infection type, the Europe molecular diagnostics for infectious disease market is bifurcated into point-of-care testing and laboratory testing. The Point-of-care testing is further segmented into bacteria, viral, fungi, and others. Similarly, laboratory testing is further categorized into bacteria, viral, fungi, and others. The bacteria segment, by point-of-care testing, held the largest Europe molecular diagnostics for infectious disease market share in 2022. Additionally, the bacteria segment, by laboratory testing, held the largest Europe molecular diagnostics for infectious disease market share in 2022.

Based on country, the Europe molecular diagnostics for infectious disease market is categorized into Germany, the UK, France, Italy, Spain, Austria, Belgium, the Netherlands, Luxembourg, and the Rest of Europe. Germany dominated the Europe molecular diagnostics for infectious disease market in 2022.

Abbott Laboratories, bioMerieux SA, Bruker Corp, Danaher Corp, DiaSorin SpA, F. Hoffmann-La Roche Ltd, Hologic Inc, Molzym GmbH & Co KG, Siemens Healthineers AG, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe molecular diagnostics for infectious disease market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Molecular Diagnostic for Infectious Diseases Market - Key Industry Dynamics

4.1 Market Drivers:
- 4.1.1 Surging Prevalence of Infectious Disease Globally
- 4.1.2 Rising Application of Molecular Diagnostics in Veterinary Infectious Diseases
4.2 Market Restraints
- 4.2.1 Limitations Associated with Molecular Testing
4.3 Market Opportunities
- 4.3.1 Advancements in Molecular Diagnostics Technologies
4.4 Future Trends
- 4.4.1 Molecular Diagnostics for Infectious Diseases in Personalized Medicine
4.5 Impact Analysis:

5. Molecular Diagnostic for Infectious Diseases Market - Europe Market Analysis

5.1 Europe Molecular Diagnostic for Infectious Diseases Market Revenue (US$ Mn), 2022 - 2030

6. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Type

6.1 Overview
6.2 Europe Molecular Diagnostic for Infectious Diseases Market Revenue Share, by Type, 2022 & 2030 (%)
6.3 Point-of-Care Testing
- 6.3.1 Overview
- 6.3.2 Point-of-Care Testing: Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Laboratory Testing
- 6.4.1 Overview
- 6.4.2 Laboratory Testing: Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by End User

7.1 Overview
7.2 Europe Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing and Laboratory Testing by End User, 2022 & 2030 (%)
- 7.2.1 Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)
- 7.2.2 Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)

8. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Application, 2022 & 2030 (%)
8.3 Point-of-Care Testing
- 8.3.1 Overview
- 8.3.2 Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)
8.4 Laboratory Testing
- 8.4.1 Overview
- 8.4.2 Europe: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)

9. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Disease Type

9.1 Overview
9.2 Europe Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Disease Type, 2022 & 2030 (%)
9.3 Point-of-Care Testing
- 9.3.1 Overview
- 9.3.2 Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)
  - 9.3.2.1 Europe Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)
9.4 Laboratory Testing
- 9.4.1 Overview
- 9.4.2 Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)
  - 9.4.2.1 Europe Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)

10. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Infection Type

10.1 Overview
10.2 Europe Molecular Diagnostic for Infectious Diseases Market Revenue Share, For Point-of-Care Testing by Infection Type, 2022 & 2030 (%)
10.3 Point-of-Care Testing
- 10.3.1 Overview
- 10.3.2 Europe Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)
10.4 Laboratory Testing
- 10.4.1 Overview
- 10.4.2 Europe Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)

11. Europe Molecular Diagnostic for Infectious Diseases Market - Country Analysis

11.1 Europe Molecular Diagnostic for Infectious Diseases Market, Revenue and Forecast to 2030
- 11.1.1 Overview
- 11.1.2 Europe Molecular Diagnostic for Infectious Diseases Market, by Country
  - 11.1.2.1 UK
    - 11.1.2.1.1 UK Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.1.2 UK: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.1.3 UK: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.1.4 UK: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.1.5 UK: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.1.6 UK: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.1.7 UK: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.1.7.1 UK: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)
    - 11.1.2.1.8 UK: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.1.8.1 UK: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)
    - 11.1.2.1.9 UK: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)
    - 11.1.2.1.10 UK: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)
  - 11.1.2.2 Germany
    - 11.1.2.2.1 Germany Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.2.2 Germany: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.2.3 Germany: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.2.4 Germany: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.2.5 Germany: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.2.6 Germany: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.2.7 Germany: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.2.7.1 Germany: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)
    - 11.1.2.2.8 Germany: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.2.8.1 Germany: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)
    - 11.1.2.2.9 Germany: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)
    - 11.1.2.2.10 Germany: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)
  - 11.1.2.3 France
    - 11.1.2.3.1 France Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.3.2 France: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.3.3 France: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.3.4 France: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.3.5 France: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.3.6 France: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.3.7 France: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.3.7.1 France: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)
    - 11.1.2.3.8 France: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.3.8.1 France: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)
    - 11.1.2.3.9 France: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)
    - 11.1.2.3.10 France: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)
  - 11.1.2.4 Italy
    - 11.1.2.4.1 Italy Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.4.2 Italy: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.4.3 Italy: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.4.4 Italy: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.4.5 Italy: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.4.6 Italy: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.4.7 Italy: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.4.7.1 Italy: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)
    - 11.1.2.4.8 Italy: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.4.8.1 Italy: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)
    - 11.1.2.4.9 Italy: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)
    - 11.1.2.4.10 Italy: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)
  - 11.1.2.5 Spain
    - 11.1.2.5.1 Spain Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.2 Spain: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.5.3 Spain: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.5.4 Spain: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.5.5 Spain: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.5.6 Spain: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.5.7 Spain: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.5.7.1 Spain: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)
    - 11.1.2.5.8 Spain: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.5.8.1 Spain: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)
    - 11.1.2.5.9 Spain: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)
    - 11.1.2.5.10 Spain: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)
  - 11.1.2.6 Austria
    - 11.1.2.6.1 Austria Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.6.2 Austria: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.6.3 Austria: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.6.4 Austria: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.6.5 Austria: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.6.6 Austria: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.6.7 Austria: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.6.7.1 Austria: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)
    - 11.1.2.6.8 Austria: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.6.8.1 Austria: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)
    - 11.1.2.6.9 Austria: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)
    - 11.1.2.6.10 Austria: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)
  - 11.1.2.7 Belgium
    - 11.1.2.7.1 Belgium Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.7.2 Belgium: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.7.3 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.7.4 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.7.5 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.7.6 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.7.7 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.7.7.1 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)
    - 11.1.2.7.8 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.7.8.1 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)
    - 11.1.2.7.9 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)
    - 11.1.2.7.10 Belgium: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)
  - 11.1.2.8 Luxembourg
    - 11.1.2.8.1 Luxembourg Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.8.2 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.8.3 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.8.4 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.8.5 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.8.6 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.8.7 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.8.7.1 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)
    - 11.1.2.8.8 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.8.8.1 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)
    - 11.1.2.8.9 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)
    - 11.1.2.8.10 Luxembourg: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)
  - 11.1.2.9 The Netherlands
    - 11.1.2.9.1 The Netherlands Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.9.2 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.9.3 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.9.4 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.9.5 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.9.6 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.9.7 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.9.7.1 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)
    - 11.1.2.9.8 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.9.8.1 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)
    - 11.1.2.9.9 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)
    - 11.1.2.9.10 The Netherlands: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)
  - 11.1.2.10 Rest of Europe
    - 11.1.2.10.1 Rest of Europe Molecular Diagnostic for Infectious Diseases Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.10.2 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, by Type, 2020-2030 (US$ Million)
    - 11.1.2.10.3 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.10.4 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by End User, 2020-2030 (US$ Million)
    - 11.1.2.10.5 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.10.6 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Application, 2020-2030 (US$ Million)
    - 11.1.2.10.7 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.10.7.1 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Point-of-Care Testing, 2020-2030 (US$ Million)
    - 11.1.2.10.8 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Disease Type, 2020-2030 (US$ Million)
    - 11.1.2.10.8.1 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Sepsis by Laboratory Testing, 2020-2030 (US$ Million)
    - 11.1.2.10.9 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Point-of-Care Testing by Infection Type, 2020-2030 (US$ Million)
    - 11.1.2.10.10 Rest of Europe: Molecular Diagnostic for Infectious Diseases Market, for Laboratory Testing by Infection Type, 2020-2030 (US$ Million)

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Abbott Laboratories
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Thermo Fisher Scientific Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 bioMerieux SA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Danaher Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Hologic Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Siemens Healthineers AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Bruker Corp
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Molzym GmbH & Co KG
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 DiaSorin SpA
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

欧州の感染症用分子診断：2030年市場予測- 地域別分析- タイプ別、エンドユーザー別、用途別、疾患タイプ別、感染タイプ別

Europe Molecular Diagnostics for Infectious Disease Market Forecast to 2030 - Regional Analysis - by Type (Point-of-Care Testing and Laboratory Testing), End User, Application, Disease Type, Infection Type

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章欧州感染症用分子診断市場- 主要産業力学

第5章感染症用分子診断市場-欧州市場分析

第6章欧州感染症用分子診断市場-2030年までの収益と予測-タイプ別

第7章欧州感染症用分子診断市場：2030年までの収益と予測：エンドユーザー別

第8章欧州感染症用分子診断市場：2030年までの収益と予測：用途別

第9章欧州感染症用分子診断市場：2030年までの収益と予測：疾患タイプ別

第10章欧州感染症用分子診断市場：2030年までの収益と予測：感染症タイプ別

第11章欧州感染症用分子診断市場：国別分析

第12章業界情勢

第13章企業プロファイル

第14章付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Europe Molecular Diagnostic for Infectious Diseases Market - Key Industry Dynamics

5. Molecular Diagnostic for Infectious Diseases Market - Europe Market Analysis

6. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Type

7. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by End User

8. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Application

9. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Disease Type

10. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Infection Type

11. Europe Molecular Diagnostic for Infectious Diseases Market - Country Analysis

12. Industry Landscape

13. Company Profiles

14. Appendix

欧州の感染症用分子診断：2030年市場予測- 地域別分析- タイプ別、エンドユーザー別、用途別、疾患タイプ別、感染タイプ別

Europe Molecular Diagnostics for Infectious Disease Market Forecast to 2030 - Regional Analysis - by Type (Point-of-Care Testing and Laboratory Testing), End User, Application, Disease Type, Infection Type

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 欧州感染症用分子診断市場- 主要産業力学

第5章 感染症用分子診断市場-欧州市場分析

第6章 欧州感染症用分子診断市場-2030年までの収益と予測-タイプ別

第7章 欧州感染症用分子診断市場：2030年までの収益と予測：エンドユーザー別

第8章 欧州感染症用分子診断市場：2030年までの収益と予測：用途別

第9章 欧州感染症用分子診断市場：2030年までの収益と予測：疾患タイプ別

第10章 欧州感染症用分子診断市場：2030年までの収益と予測：感染症タイプ別

第11章 欧州感染症用分子診断市場：国別分析

第12章 業界情勢

第13章 企業プロファイル

第14章 付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Europe Molecular Diagnostic for Infectious Diseases Market - Key Industry Dynamics

5. Molecular Diagnostic for Infectious Diseases Market - Europe Market Analysis

6. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Type

7. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by End User

8. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Application

9. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Disease Type

10. Europe Molecular Diagnostic for Infectious Diseases Market - Revenue and Forecast to 2030 - by Infection Type

11. Europe Molecular Diagnostic for Infectious Diseases Market - Country Analysis

12. Industry Landscape

13. Company Profiles

14. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章欧州感染症用分子診断市場- 主要産業力学

第5章感染症用分子診断市場-欧州市場分析

第6章欧州感染症用分子診断市場-2030年までの収益と予測-タイプ別

第7章欧州感染症用分子診断市場：2030年までの収益と予測：エンドユーザー別

第8章欧州感染症用分子診断市場：2030年までの収益と予測：用途別

第9章欧州感染症用分子診断市場：2030年までの収益と予測：疾患タイプ別

第10章欧州感染症用分子診断市場：2030年までの収益と予測：感染症タイプ別

第11章欧州感染症用分子診断市場：国別分析

第12章業界情勢

第13章企業プロファイル

第14章付録